Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Isoniazid-induced subacute cutaneous lupus erythematosus in an HIV-positive woman: a rare side effect to be aware of with the current expansion of isoniazid preventive therapy.

Luwanda LB, Gamell A.

Pan Afr Med J. 2018 Apr 6;29:200. doi: 10.11604/pamj.2018.29.200.12081. eCollection 2018. No abstract available.

2.

Cutaneous lupus erythematosus: Reflecting on practice-changing observations over the past 50 years.

Callen JP.

Clin Dermatol. 2018 Jul - Aug;36(4):442-449. doi: 10.1016/j.clindermatol.2018.04.002. Epub 2018 Apr 10. Review.

PMID:
30047428
3.

Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.

Spinelli FR, Moscarelli E, Ceccarelli F, Miranda F, Perricone C, Truglia S, Garufi C, Massaro L, Morello F, Alessandri C, Valesini G, Conti F.

Lupus. 2018 Sep;27(10):1616-1623. doi: 10.1177/0961203318781008. Epub 2018 Jun 28.

PMID:
29954281
4.

The Coexistence of Systemic Lupus Erythematosus and Psoriasis: Is It Possible?

Gunawan H, Awalia A, Soeroso J.

Acta Med Indones. 2018 Apr;50(2):144-150.

5.

Lupus retinopathy: a marker of active systemic lupus erythematosus.

Seth G, Chengappa KG, Misra DP, Babu R, Belani P, Shanoj KC, Kumar G, Negi VS.

Rheumatol Int. 2018 Aug;38(8):1495-1501. doi: 10.1007/s00296-018-4083-4. Epub 2018 Jun 13.

PMID:
29948002
6.

Pruritus in Autoimmune Connective Tissue Diseases.

Smith GP, Argobi Y.

Dermatol Clin. 2018 Jul;36(3):267-275. doi: 10.1016/j.det.2018.02.013. Epub 2018 Apr 26. Review.

PMID:
29929598
7.

Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus.

Penha MÁ, Libório RDS, Miot HA.

An Bras Dermatol. 2018 Jun;93(3):467-469. doi: 10.1590/abd1806-4841.20187561. No abstract available.

8.

Analysis of possible structures of inducible skin-associated lymphoid tissue in lupus erythematosus profundus.

Kogame T, Yamashita R, Hirata M, Kataoka TR, Kamido H, Ueshima C, Matsui M, Nomura T, Kabashima K.

J Dermatol. 2018 Sep;45(9):1117-1121. doi: 10.1111/1346-8138.14498. Epub 2018 Jun 13.

PMID:
29897143
9.

Discoid lupus erythematosus following herpes zoster.

Anyanwu CO, Sommer LL, Kuzyshyn H, Camacho JM, Eid HM, Heymann WR.

Cutis. 2018 May;101(5):370-372.

PMID:
29894527
10.

Intravenous Immunoglobulins as a new opportunity to treat discoid lupus erythematosus: A case report and review of the literature.

Tenti S, Fabbroni M, Mancini V, Russo F, Galeazzi M, Fioravanti A.

Autoimmun Rev. 2018 Aug;17(8):791-795. doi: 10.1016/j.autrev.2018.02.010. Epub 2018 Jun 6. Review.

PMID:
29885539
11.

JAK-STAT signaling pathway inhibition: a role for treatment of discoid lupus erythematosus and dermatomyositis.

Kahn JS, Deverapalli SC, Rosmarin DM.

Int J Dermatol. 2018 Aug;57(8):1007-1014. doi: 10.1111/ijd.14064. Epub 2018 Jun 5. Review.

PMID:
29873082
12.

Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark.

Petersen MP, Möller S, Bygum A, Voss A, Bliddal M.

Lupus. 2018 Aug;27(9):1424-1430. doi: 10.1177/0961203318777103. Epub 2018 May 22.

PMID:
29788808
13.

Drug-induced Subacute Cutaneous Lupus Erythematosus Caused by a Topical Beta Blocker - Timolol.

Bilewicz-Stebel M, Miziołek B, Bergler-Czop B, Stańkowska A.

Acta Dermatovenerol Croat. 2018 Apr;26(1):44-47. Review.

PMID:
29782299
14.

Subcutaneous Panniculitis-Like T-Cell Lymphoma Versus Lupus Erythematosus Panniculitis: Distinction by Means of the Periadipocytic Cell Proliferation Index.

Sitthinamsuwan P, Pattanaprichakul P, Treetipsatit J, Pongpruttipan T, Sukpanichnant S, Pincus LB, McCalmont TH.

Am J Dermatopathol. 2018 Aug;40(8):567-574. doi: 10.1097/DAD.0000000000001173.

PMID:
29742552
15.

CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.

Niederkorn A, Frühauf J, Schwantzer G, Wutte N, Painsi C, Werner S, Stradner M, Berghold A, Hermann J, Aberer E.

Arch Dermatol Res. 2018 Aug;310(6):485-493. doi: 10.1007/s00403-018-1836-6. Epub 2018 May 4.

PMID:
29728857
16.

Coexistence of chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Nascimento LLD, Enokihara MMSES, Vasconcellos MRA.

An Bras Dermatol. 2018 Mar;93(2):274-276. doi: 10.1590/abd1806-4841.20186992.

17.

Clinical and dermoscopic spectrum of discoid lupus erythematosus: novel observations from lips and oral mucosa.

Salah E.

Int J Dermatol. 2018 Jul;57(7):830-836. doi: 10.1111/ijd.14015. Epub 2018 Apr 27.

PMID:
29700807
18.

A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus.

Chen X, Wang S, Li L.

Medicine (Baltimore). 2018 Apr;97(16):e0375. doi: 10.1097/MD.0000000000010375.

19.

Photoprotection awareness and practices among patients with systemic lupus erythematosus and its association with disease activity and severity.

Abdul Kadir WD, Jamil A, Shaharir SS, Md Nor N, Abdul Gafor AH.

Lupus. 2018 Jul;27(8):1287-1295. doi: 10.1177/0961203318770016. Epub 2018 Apr 17.

PMID:
29665756
20.

Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.

Ugarte A, Porta S, Ríos R, Martinez-Zapico A, Ortego-Centeno N, Agesta N, Ruiz-Irastorza G.

Lupus. 2018 Sep;27(10):1718-1722. doi: 10.1177/0961203318768877. Epub 2018 Apr 10.

PMID:
29635998

Supplemental Content

Loading ...
Support Center